cardiology careers collections past issues search home
     

J Am Coll Cardiol, 2002; 40:2034-2038
© 2002 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Azeka, E.
Right arrow Articles by Alcides Bocchi, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Azeka, E.
Right arrow Articles by Alcides Bocchi, E.

Delisting of infants and children from the heart transplantation waiting list after carvedilol treatment

Estela Azeka, MD, PhDa,*, José Antonio Franchini Ramires, MD, PhD, FACCa, Constante Vallera and Edimar Alcides Bocchi, MD, PhDa

a Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil



View larger version (12K):

[in a new window]
 
Figure 1 Left ventricular ejection fraction (LVEF) by radionuclide ventriculography in the carvedilol and placebo groups.

 


View larger version (11K):

[in a new window]
 
Figure 2 Fractional shortening (FS) by echocardiogram in the carvedilol and placebo groups.

 


View larger version (11K):

[in a new window]
 
Figure 3 Left ventricular diastolic index (LVDI) by echocardiogram in the carvedilol and placebo groups.

 




 
  cardiology careers collections past issues search home